Vistagen Therapeutics Statistics
Total Valuation
VTGN has a market cap or net worth of $87.12 million. The enterprise value is -$19.26 million.
Important Dates
The next confirmed earnings date is Thursday, November 7, 2024, after market close.
| Earnings Date | Nov 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
VTGN has 27.06 million shares outstanding. The number of shares has increased by 255.96% in one year.
| Shares Outstanding | 27.06M |
| Shares Change (YoY) | +255.96% |
| Shares Change (QoQ) | +0.27% |
| Owned by Insiders (%) | 0.26% |
| Owned by Institutions (%) | 22.87% |
| Float | 15.84M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 83.47 |
| Forward PS | n/a |
| PB Ratio | 0.83 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 17.77, with a Debt / Equity ratio of 0.02.
| Current Ratio | 17.77 |
| Quick Ratio | 17.38 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -59.46% and return on invested capital (ROIC) is -40.79%.
| Return on Equity (ROE) | -59.46% |
| Return on Assets (ROA) | -37.09% |
| Return on Capital (ROIC) | -40.79% |
| Revenue Per Employee | $24,275 |
| Profits Per Employee | -$829,800 |
| Employee Count | 40 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, VTGN has paid $1,000 in taxes.
| Income Tax | 1,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -3.88% in the last 52 weeks. The beta is 0.78, so VTGN's price volatility has been lower than the market average.
| Beta (5Y) | 0.78 |
| 52-Week Price Change | -3.88% |
| 50-Day Moving Average | 3.12 |
| 200-Day Moving Average | 3.97 |
| Relative Strength Index (RSI) | 60.97 |
| Average Volume (20 Days) | 224,021 |
Short Selling Information
The latest short interest is 644,717, so 2.38% of the outstanding shares have been sold short.
| Short Interest | 644,717 |
| Short Previous Month | 679,925 |
| Short % of Shares Out | 2.38% |
| Short % of Float | 4.07% |
| Short Ratio (days to cover) | 4.13 |
Income Statement
In the last 12 months, VTGN had revenue of $971,000 and -$33.19 million in losses. Loss per share was -$1.32.
| Revenue | 971,000 |
| Gross Profit | 971,000 |
| Operating Income | -38.15M |
| Pretax Income | -29.36M |
| Net Income | -33.19M |
| EBITDA | -38.03M |
| EBIT | -38.15M |
| Loss Per Share | -$1.32 |
Full Income StatementBalance Sheet
The company has $108.36 million in cash and $1.99 million in debt, giving a net cash position of $106.37 million or $3.93 per share.
| Cash & Cash Equivalents | 108.36M |
| Total Debt | 1.99M |
| Net Cash | 106.37M |
| Net Cash Per Share | $3.93 |
| Equity (Book Value) | 104.80M |
| Book Value Per Share | 3.87 |
| Working Capital | 104.60M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$28.79 million and capital expenditures -$103,000, giving a free cash flow of -$28.89 million.
| Operating Cash Flow | -28.79M |
| Capital Expenditures | -103,000 |
| Free Cash Flow | -28.89M |
| FCF Per Share | -$1.07 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -3,929.35% |
| Pretax Margin | -3,418.23% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | -2,431.77% |
Dividends & Yields
VTGN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -255.96% |
| Shareholder Yield | -255.96% |
| Earnings Yield | -38.10% |
| FCF Yield | -33.17% |
Analyst Forecast
The average price target for VTGN is $13.50, which is 319.26% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $13.50 |
| Price Target Difference | 319.26% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 201.61% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on June 7, 2023. It was a reverse split with a ratio of 0.0333333:1.
| Last Split Date | Jun 7, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.0333333:1 |
Scores
VTGN has an Altman Z-Score of 2.04 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.04 |
| Piotroski F-Score | 2 |